HK1080715A1 - Process for preparing a sterile high molecular weight hyaluronic acid formulation - Google Patents

Process for preparing a sterile high molecular weight hyaluronic acid formulation

Info

Publication number
HK1080715A1
HK1080715A1 HK06100556A HK06100556A HK1080715A1 HK 1080715 A1 HK1080715 A1 HK 1080715A1 HK 06100556 A HK06100556 A HK 06100556A HK 06100556 A HK06100556 A HK 06100556A HK 1080715 A1 HK1080715 A1 HK 1080715A1
Authority
HK
Hong Kong
Prior art keywords
preparing
molecular weight
high molecular
hyaluronic acid
weight hyaluronic
Prior art date
Application number
HK06100556A
Other languages
English (en)
Inventor
Stefano Carlino
Original Assignee
Medidom Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31502852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1080715(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medidom Lab filed Critical Medidom Lab
Publication of HK1080715A1 publication Critical patent/HK1080715A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
HK06100556A 2002-08-07 2006-01-13 Process for preparing a sterile high molecular weight hyaluronic acid formulation HK1080715A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02405681 2002-08-07
PCT/IB2003/003524 WO2004014399A1 (en) 2002-08-07 2003-08-04 Process for preparing a sterile high molecular weight hyaluronic acid formulation

Publications (1)

Publication Number Publication Date
HK1080715A1 true HK1080715A1 (en) 2006-05-04

Family

ID=31502852

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06100556A HK1080715A1 (en) 2002-08-07 2006-01-13 Process for preparing a sterile high molecular weight hyaluronic acid formulation

Country Status (21)

Country Link
US (1) US7939655B2 (es)
EP (1) EP1526859B1 (es)
JP (1) JP4597672B2 (es)
KR (1) KR101169473B1 (es)
CN (1) CN100366296C (es)
AU (1) AU2003255892B2 (es)
BR (1) BRPI0312669B8 (es)
CA (1) CA2492739C (es)
DK (1) DK1526859T3 (es)
ES (1) ES2397382T3 (es)
HK (1) HK1080715A1 (es)
HR (1) HRP20041230B1 (es)
IL (1) IL166231A (es)
MX (1) MXPA05000533A (es)
NO (1) NO334523B1 (es)
NZ (1) NZ538019A (es)
PL (1) PL217885B1 (es)
PT (1) PT1526859E (es)
SI (1) SI1526859T1 (es)
WO (1) WO2004014399A1 (es)
ZA (1) ZA200500259B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1326883C (zh) * 2005-11-04 2007-07-18 山东福瑞达生物化工有限公司 一种透明质酸钙的制备方法
CN100478360C (zh) * 2006-10-31 2009-04-15 山东福瑞达生物化工有限公司 将浓缩用于透明质酸或其盐的生产的方法
KR20100094982A (ko) 2007-11-13 2010-08-27 바이오-테크널러지 제너럴 (이스라엘) 리미티드 점탄성 바이오폴리머의 희석식 여과 멸균 방법
KR101449687B1 (ko) * 2008-03-13 2014-10-14 주식회사 바이오랜드 저분자 및 고분자 히알루론산과 유근피로부터 분리된다당체 추출물을 함유하는 노화방지용 조성물
US8283463B2 (en) 2010-02-09 2012-10-09 Bausch & Lomb Incorporated Sterile hyaluronic acid solutions
KR101379930B1 (ko) 2011-12-12 2014-04-14 가톨릭대학교 산학협력단 후발성 백내장 억제용 조성물 및 이의 제조 방법
KR20200130685A (ko) 2018-02-06 2020-11-19 리젠 랩 에스에이 가교된 히알루론산 및 prp/bmc와의 조합물
JP7457390B2 (ja) * 2018-09-20 2024-03-28 香港科技大学 点眼組成物
WO2020057606A1 (en) * 2018-09-20 2020-03-26 The Hong Kong University Of Science And Technology Eyedrop compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US5093487A (en) * 1986-01-06 1992-03-03 Mobay Corporation Low viscosity high molecular weight filter sterilizable hyaluronic acid
JP2893451B2 (ja) * 1988-08-09 1999-05-24 昭和産業株式会社 高分子量のヒアルロン酸を製造する方法
IT1251151B (it) * 1991-08-05 1995-05-04 Fidia Spa Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
IT1259090B (it) * 1992-04-17 1996-03-11 Fidia Spa Biomaterialli per protesi d'osso
JP2844296B2 (ja) * 1993-06-29 1999-01-06 正樹 佐久間 真空濃縮装置
CN1064372C (zh) * 1994-08-26 2001-04-11 顾其胜 透明质酸钠制剂的制备方法
KR19980080116A (ko) 1997-03-27 1998-11-25 히라따 다다시 히알루론산 나트륨의 정제법
CH692919A5 (fr) * 1999-01-28 2002-12-13 Trb Chemedica S A Procédé de purification de l'acide hyaluronique à poids moléculaire élevé.
US6660853B2 (en) * 2000-12-15 2003-12-09 Al Prescott Method for purifying high molecular weight hyaluronic acid
DE60117502T2 (de) 2000-12-19 2006-08-24 Seikagaku Corp. Photohärtbare Derivate von Hyaluronsäure, Verfahren zu deren Herstellung, vernetztes und photogehärtetes Derivat der Hyaluronsäure und diese enthaltendes medizinisches Material

Also Published As

Publication number Publication date
CA2492739A1 (en) 2004-02-19
ES2397382T3 (es) 2013-03-06
US20060052336A1 (en) 2006-03-09
EP1526859B1 (en) 2012-10-24
KR20050044900A (ko) 2005-05-13
BRPI0312669B1 (pt) 2015-08-11
NO334523B1 (no) 2014-03-31
CN100366296C (zh) 2008-02-06
BRPI0312669B8 (pt) 2021-05-25
HRP20041230A2 (en) 2005-06-30
SI1526859T1 (sl) 2013-01-31
NZ538019A (en) 2006-02-24
IL166231A (en) 2011-10-31
MXPA05000533A (es) 2005-04-19
NO20051181L (no) 2005-05-06
BR0312669A (pt) 2005-04-26
PL217885B1 (pl) 2014-08-29
CN1674920A (zh) 2005-09-28
JP4597672B2 (ja) 2010-12-15
CA2492739C (en) 2011-05-31
PL373893A1 (en) 2005-09-19
WO2004014399A1 (en) 2004-02-19
AU2003255892A1 (en) 2004-02-25
IL166231A0 (en) 2006-01-15
JP2005536530A (ja) 2005-12-02
HRP20041230B1 (hr) 2013-02-28
ZA200500259B (en) 2005-12-28
KR101169473B1 (ko) 2012-07-30
EP1526859A1 (en) 2005-05-04
US7939655B2 (en) 2011-05-10
PT1526859E (pt) 2013-01-25
DK1526859T3 (da) 2013-02-04
AU2003255892B2 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
HK1080715A1 (en) Process for preparing a sterile high molecular weight hyaluronic acid formulation
EP1496037A4 (en) HYALURONIC ACID MODIFICATION PRODUCT
AU2003235381A1 (en) Method for preparing polymer micelle pharmaceutical preparation containing drug for injection
IL195011A0 (en) Process for preparing piperidine derivatives
AU2003281298A1 (en) A method for monitoring the properties of pharmaceutical articles
IL172444A0 (en) Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative
HK1078863A1 (en) Process for preparing (s)-pantoprazole
AU2002358103A1 (en) Process for recovering a polymer a solution
IL166698A0 (en) Process for preparing paste-extruded sulfonamide compositions
AU2003283870A1 (en) Process for preparing a composition
AU2003237052A8 (en) Process for preparing (r)-aryloxypropionic acid ester derivatives
AU2003263188A1 (en) At least two-stage process for preparing propylene polymer compositions
PL372595A1 (en) Process for preparing conjugated linoleic acid
HUP0200342A3 (en) Novel process for preparing alendronic acid
EP1483365B8 (en) Apparatus for preparing a biocompatible matrix
AU2003242338A1 (en) Medicine trial production supporting system
IL164901A (en) Process for preparing optically active beta-aminoketones
GB2403408B (en) Process for preparing a stable anthelmintic suspension formulation
AU2003249491A1 (en) Hyaluronic acid derivatives
AU2003275898A1 (en) Process for preparing an adenovirus-containing preparation
AU2003248987A1 (en) Process for preparing 7-azaindoles
IL166514A0 (en) A process for preparing hydroxyazapirone derivatives
AU2002953369A0 (en) Free radical polymerisation process for microgel preparation
AU2003221482A1 (en) Novel cinnamate salts, method for production and use thereof as medicaments
GB0206095D0 (en) Process for preparing phosphonate-terminated polymers

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20230803